MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FEHSKE, K. J.
Right arrow Articles by VELDEN, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FEHSKE, K. J.
Right arrow Articles by VELDEN, L. M.

Molecular Pharmacology, Vol 16, 778-789, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

The Lone Tryptophan Residue of Human Serum Albumin as Part of the Specific Warfarin Binding Site

Binding of Dicoumarol to the Warfarin, Indole and Benzodiazepine Binding Sites

KLAUS J. FEHSKE 1, WALTER E. MÜLLER 1, UWE WOLLERT 1, and LUZIAN M. VELDEN 2

1 Pharmakologisches Institut der Universität Mainz, D-6500 Mainz, West-Germany
2 Radioastronomisches Institut der Universität Bonn, D-5300 Bonn, West-Germany

The interaction of warfarin and dicoumarol with tryptophan- and tyrosine-modified human serum albumin derivatives was investigated by equilibrium dialysis and circular dichroism measurements. The binding of warfarin to its specific high-affinity binding site is strongly reduced after the modification of the lone tryptophan residue of human serum albumin with three different reagents, while the modification of tyrosine residues has nearly no effect on the binding of warfarin to this site. It is concluded that the lone tryptophan residue is part of the warfarin binding site which is clearly separated from the specific indole and benzodiazepine binding site. Evidence is presented that dicoumarol interacts with the warfarin as well as the indole and benzodiazepine binding site of the human serum albumin molecule. A highly reactive tyrosine residue specifically involved in the indole and benzodiazepine binding site seems to be important for the dicoumarol binding, too. Its nitration with tetranitromethane differently affects the four induced circular dichroism bands of dicoumarol bound to human serum albumin. This effect has been qualitatively and quantitatively characterized by the resolution of the induced circular dichroism spectrum of dicoumarol bound to human serum albumin into the Gaussian component bands using a computer program. The identification of the lone tryptophan residue as a part of the warfarin binding site of human serum albumin is a significant step forward in localizing this important drug binding site.

Submitted on May 14, 1979
Accepted on August 23, 1979




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. Dockal, D. C. Carter, and F. Ruker
The Three Recombinant Domains of Human Serum Albumin. STRUCTURAL CHARACTERIZATION AND LIGAND BINDING PROPERTIES
J. Biol. Chem., October 8, 1999; 274(41): 29303 - 29310.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Petitpas, A. A. Bhattacharya, S. Twine, M. East, and S. Curry
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin. ANATOMY OF DRUG SITE I
J. Biol. Chem., June 15, 2001; 276(25): 22804 - 22809.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics